Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

Hirokazu Yokoyama, Hiroshi Hirose, Hideki Ohgo, Ikuo Saito

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Background/Aims Since a novel polypeptide named adiponectin was shown to prevent the development of steatosis and steatohepatitis in animal models, we studied whether it was also possible in a clinical situation. Methods Associations between serum adiponectin levels and serum transaminase activities were studied in 791 Japanese males who were not heavy drinkers, and had no autoimmune or HBV- or HCV-induced liver diseases. Results Various markers of metabolic diseases including levels of body mass index (BMI), serum triglyceride, total cholesterol, and insulin resistance assessed by the homeostasis model were significantly higher in subjects with increased transaminase activities when compared to those with normal activities. Single regression analyses demonstrated that the logarithmic serum adiponectin level was inversely correlated with the levels of logarithmic serum AST (r=-0.229, P<0.0001), ALT (r=-0.305, P<0.0001), and γGTP (r=-0.278, P<0.0001). Even in multiple regression analyses in which subjects' age and levels of BMI, serum triglyceride, total cholesterol, and insulin resistance were adjusted, the inverse correlations were significant (P=0.0426, 0.0332, and 0.0011, respectively). Conclusions Hypoadiponectinemia may worsen liver diseases associated with metabolic diseases in clinical cases. In addition to aggravation of insulin resistance and hyperlipidemia, some hypoadiponectinemia specific mechanisms may stand behind the association.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalJournal of Hepatology
Volume41
Issue number1
DOIs
Publication statusPublished - 2004 Jul

Fingerprint

Adiponectin
Transaminases
Serum
Insulin Resistance
Metabolic Diseases
Liver Diseases
Triglycerides
Body Mass Index
Cholesterol
Regression Analysis
Fatty Liver
Guanosine Triphosphate
Hyperlipidemias
Homeostasis
Animal Models
Peptides

Keywords

  • Adiponectin
  • Fatty liver
  • Insulin resistance

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. / Yokoyama, Hirokazu; Hirose, Hiroshi; Ohgo, Hideki; Saito, Ikuo.

In: Journal of Hepatology, Vol. 41, No. 1, 07.2004, p. 19-24.

Research output: Contribution to journalArticle

@article{dfc7d5f563be4e85b47260deddbfe0e9,
title = "Inverse association between serum adiponectin level and transaminase activities in Japanese male workers",
abstract = "Background/Aims Since a novel polypeptide named adiponectin was shown to prevent the development of steatosis and steatohepatitis in animal models, we studied whether it was also possible in a clinical situation. Methods Associations between serum adiponectin levels and serum transaminase activities were studied in 791 Japanese males who were not heavy drinkers, and had no autoimmune or HBV- or HCV-induced liver diseases. Results Various markers of metabolic diseases including levels of body mass index (BMI), serum triglyceride, total cholesterol, and insulin resistance assessed by the homeostasis model were significantly higher in subjects with increased transaminase activities when compared to those with normal activities. Single regression analyses demonstrated that the logarithmic serum adiponectin level was inversely correlated with the levels of logarithmic serum AST (r=-0.229, P<0.0001), ALT (r=-0.305, P<0.0001), and γGTP (r=-0.278, P<0.0001). Even in multiple regression analyses in which subjects' age and levels of BMI, serum triglyceride, total cholesterol, and insulin resistance were adjusted, the inverse correlations were significant (P=0.0426, 0.0332, and 0.0011, respectively). Conclusions Hypoadiponectinemia may worsen liver diseases associated with metabolic diseases in clinical cases. In addition to aggravation of insulin resistance and hyperlipidemia, some hypoadiponectinemia specific mechanisms may stand behind the association.",
keywords = "Adiponectin, Fatty liver, Insulin resistance",
author = "Hirokazu Yokoyama and Hiroshi Hirose and Hideki Ohgo and Ikuo Saito",
year = "2004",
month = "7",
doi = "10.1016/j.jhep.2004.03.003",
language = "English",
volume = "41",
pages = "19--24",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

AU - Yokoyama, Hirokazu

AU - Hirose, Hiroshi

AU - Ohgo, Hideki

AU - Saito, Ikuo

PY - 2004/7

Y1 - 2004/7

N2 - Background/Aims Since a novel polypeptide named adiponectin was shown to prevent the development of steatosis and steatohepatitis in animal models, we studied whether it was also possible in a clinical situation. Methods Associations between serum adiponectin levels and serum transaminase activities were studied in 791 Japanese males who were not heavy drinkers, and had no autoimmune or HBV- or HCV-induced liver diseases. Results Various markers of metabolic diseases including levels of body mass index (BMI), serum triglyceride, total cholesterol, and insulin resistance assessed by the homeostasis model were significantly higher in subjects with increased transaminase activities when compared to those with normal activities. Single regression analyses demonstrated that the logarithmic serum adiponectin level was inversely correlated with the levels of logarithmic serum AST (r=-0.229, P<0.0001), ALT (r=-0.305, P<0.0001), and γGTP (r=-0.278, P<0.0001). Even in multiple regression analyses in which subjects' age and levels of BMI, serum triglyceride, total cholesterol, and insulin resistance were adjusted, the inverse correlations were significant (P=0.0426, 0.0332, and 0.0011, respectively). Conclusions Hypoadiponectinemia may worsen liver diseases associated with metabolic diseases in clinical cases. In addition to aggravation of insulin resistance and hyperlipidemia, some hypoadiponectinemia specific mechanisms may stand behind the association.

AB - Background/Aims Since a novel polypeptide named adiponectin was shown to prevent the development of steatosis and steatohepatitis in animal models, we studied whether it was also possible in a clinical situation. Methods Associations between serum adiponectin levels and serum transaminase activities were studied in 791 Japanese males who were not heavy drinkers, and had no autoimmune or HBV- or HCV-induced liver diseases. Results Various markers of metabolic diseases including levels of body mass index (BMI), serum triglyceride, total cholesterol, and insulin resistance assessed by the homeostasis model were significantly higher in subjects with increased transaminase activities when compared to those with normal activities. Single regression analyses demonstrated that the logarithmic serum adiponectin level was inversely correlated with the levels of logarithmic serum AST (r=-0.229, P<0.0001), ALT (r=-0.305, P<0.0001), and γGTP (r=-0.278, P<0.0001). Even in multiple regression analyses in which subjects' age and levels of BMI, serum triglyceride, total cholesterol, and insulin resistance were adjusted, the inverse correlations were significant (P=0.0426, 0.0332, and 0.0011, respectively). Conclusions Hypoadiponectinemia may worsen liver diseases associated with metabolic diseases in clinical cases. In addition to aggravation of insulin resistance and hyperlipidemia, some hypoadiponectinemia specific mechanisms may stand behind the association.

KW - Adiponectin

KW - Fatty liver

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=3442884807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442884807&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2004.03.003

DO - 10.1016/j.jhep.2004.03.003

M3 - Article

VL - 41

SP - 19

EP - 24

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 1

ER -